Latest Lead News

Alterity Therapeutics has unveiled encouraging Phase 2 trial results for ATH434, demonstrating its potential to slow disease progression in Multiple System Atrophy while maintaining a strong safety profile.

Flynn Gold has initiated its first-ever diamond drilling program at the historically rich Double Event gold prospect in Northeast Tasmania, following trenching that revealed an extensive mineralised corridor. The drilling aims to validate and expand on promising surface assay results, potentially unlocking significant value for the Golden Ridge Project.

360 Capital Group has received an unconditional $0.30 per security takeover offer from TT Investments, prompting the formation of an Independent Board Committee to evaluate the bid and advise securityholders.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

OpenLearning Limited has inked a five-year, usage-based SaaS agreement with Systems Plus College Foundation, marking a significant step in expanding its AI-powered learning platform across Southeast Asia.

Summit Minerals announces a $1.67 million capital raise through a Placement and a fully underwritten Rights Issue, aiming to accelerate exploration in Brazil and pursue new project opportunities.

Zeotech Limited has locked in a binding five-year offtake agreement with MSI, granting exclusive marketing rights for its kaolin products across key Asian markets. This deal, valued at approximately AUD 204 million, sets the stage for early cash flow generation and advancement of its low-carbon concrete additive project.

Belararox Limited has raised A$8.5 million through a two-tranche placement to accelerate copper exploration at its high-potential projects in Botswana and Argentina, setting the stage for a busy drilling and geophysics campaign.

TT Investments, led by Executive Chairman Tony Pitt, has initiated an unconditional off-market takeover offer for 360 Capital Group at $0.30 per security, representing a substantial premium to historical trading prices. The bid aims to consolidate control and may lead to delisting if ownership thresholds are met.

Yari Minerals has raised $1.5 million through a share placement to fund its first drilling campaign at the South Rolleston Coal Project, aiming to upgrade its coal resource classification and confirm metallurgical quality.

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.

MaxoTel has locked in a business finance agreement with Westpac to fund its proposed acquisition of Vonex shares, reinforcing the path to a shareholder vote on the scheme. Vonex’s independent directors continue to recommend approval, pending no better offers and expert endorsement.